As of November 6, 2026, Virax Biolabs Group Ltd is a publicly traded company (Nasdaq: VRAX). The largest insider holding is Foster James Alexander Cunliffe, the chief executive, with 287,987 shares (49.7% of shares outstanding), per Form 3 of March 18, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, February 17, 2026).
Is this your company?
About to sign with, pay or invest in Virax Biolabs Group Limited? See the free Snapshot first.
Free to see. No signup.
Is Virax Biolabs Group Ltd a real, registered company?
- Virax Biolabs Group Limited files with the SEC under CIK 1885827 (its SEC filings).
- Its shares are listed under the ticker VRAX on Nasdaq (SEC company record).
- Incorporated in E9; business address in Lanarkshire, X0, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Virax Biolabs Group Ltd in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Armistice Capital (filed 2026-02-17).
Who are Virax Biolabs Group Ltd's owners and officers?
Virax Biolabs Group Ltd: business address in Lanarkshire, X0; industry In Vitro & In Vivo Diagnostic Substances (Schedule 13G/A, 2026-05-15).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-12-18)
- : Executive Officer, Director (Form D, 2025-12-18)
- : Director (Form D, 2025-12-18)
- : Director (Form D, 2025-12-18)
- : Director (Form D, 2025-12-18)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-15 | Armistice Capital, LLC | 4.99% |
| Schedule 13G, 2026-02-17 | Armistice Capital, LLC | 9.99% |
| Schedule 13G, 2025-10-29 | James Foster | 24.9% |
| Schedule 13G/A, 2025-10-29 | James Foster | 8.3% |
| Schedule 13G/A, 2025-10-29 | James Foster | 12.9% |
| Schedule 13G/A, 2025-10-29 | James Foster | 7.3% |
Questions about who owns Virax Biolabs Group Ltd
Who owns Virax Biolabs Group Ltd?
On this page, one holder's latest ownership filing reports 5% or more of Virax Biolabs Group Ltd: James Foster (24.9%, Schedule 13G, filed 2025-10-29).
When did James Foster buy into Virax Biolabs Group Ltd?
The filings give report dates, not purchase dates. The earliest filing from James Foster on this page is the Schedule 13G, filed 2025-10-29, reporting 24.9%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Virax Biolabs Group Limited?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Virax Biolabs Group Limited: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Virax Biolabs Group Limited covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Virax Biolabs Group Ltd shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief executive: 287,987 shares (49.7% of shares outstanding) (Form 3, 2026-03-18).
Shares outstanding: 579,218 as of 2026-03-31, from the company's latest SEC cover page.
How much has Virax Biolabs Group Ltd raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-12-18 | $5M | $5M |
| Form D, 2023-10-17 | $2.15M | $2.15M |
| Form D, 2023-03-15 | $4M | $4M |
Keep reading
More on Virax Biolabs Group Limited and the records around it.
Virax Biolabs Group Limited elsewhere on the record
- Company profile and every filing Dec 2025
- Form D filing Dec 2025
Companies that share a holder
- Armistice Capital, LLC also filed stake reports on 120 other companies: Autolus Therapeutics plc (Aug 2026), Bicycle Therapeutics plc (Aug 2026), BioXcel Therapeutics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/virax-biolabs